Center for Scientific Review; Notice of Closed Meetings, 5897-5898 [2023-01833]
Download as PDF
Federal Register / Vol. 88, No. 19 / Monday, January 30, 2023 / Notices
the Paperwork Reduction Act of 1995 is
not required.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
III. Electronic Access
Persons with access to the internet
may obtain the guidance at https://
www.fda.gov/AnimalVeterinary/
GuidanceComplianceEnforcement/
GuidanceforIndustry/default.htm,
https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments, or https://
www.regulations.gov.
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: January 24, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–01764 Filed 1–27–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
lotter on DSK11XQN23PROD with NOTICES1
Notice of Interest Rate on Overdue
Debts
Section 30.18 of the Department of
Health and Human Services’ claims
collection regulations (45 CFR part 30)
provides that the Secretary shall charge
an annual rate of interest, which is
determined and fixed by the Secretary
of the Treasury after considering private
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 111⁄4%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended December 31,
2022. This rate is based on the Interest
Rates for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 254o(b)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2023–01731 Filed 1–27–23; 8:45 am]
BILLING CODE 4150–04–P
VerDate Sep<11>2014
17:30 Jan 27, 2023
Jkt 259001
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neuronal Communications
Study Section.
Date: February 23–24, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Prithi Rajan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, prithi.rajan@nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Prevention Study Section.
Date: February 23–24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Byung Min Chung, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–4056, justin.chung@
nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: February 23–24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Andrew Maxwell Wolfe,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, (301) 402–3019,
andrew.wolfe@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
5897
Integrated Review Group; Learning, Memory
and Decision Neuroscience Study Section.
Date: February 23–24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, janzr2@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Clinical Data Management and Analysis
Study Section.
Date: February 23–24, 2023.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Shivakumar V. Chittari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 408–9098, chittari.shivakumar@
nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biomaterials and Biointerfaces Study
Section.
Date: February 23–24, 2023.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shivani Sharma, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (240) 507–7661, shivani.sharma@
nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Muscle and Exercise Physiology
Study Section.
Date: February 23–24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Drug and Biologic Disposition and Toxicity
Study Section (DBDT).
Date: February 23, 2023.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\30JAN1.SGM
30JAN1
5898
Federal Register / Vol. 88, No. 19 / Monday, January 30, 2023 / Notices
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Cellular
Mechanisms in Aging and Development
Study Section.
Date: February 23–24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel Tapestry
Collection by Hilton, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Tami Jo Kingsbury, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 710Q,
Bethesda, MD 20892, (410) 274–1352,
tami.kingsbury@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Federal Emergency
Management Agency (FEMA),
Department of Homeland Security
(DHS).
ACTION: Notice.
website at https://www.fema.gov/grants/
preparedness/firefighters, as well as at
https://www.grants.gov.
DATES: Grant applications for the FY
2022 AFG Program are being accepted
electronically through the FEMA Grant
Outcomes (FEMA GO) system at https://
go.fema.gov/, through 5 p.m. ET on
February 10, 2023.
ADDRESSES: DHS/FEMA/GPD Assistance
to Firefighters Grant Branch, 400 C
Street SW, 3N, Washington, DC 20472–
3635.
FOR FURTHER INFORMATION CONTACT:
Catherine Patterson, Chief, Assistance to
Firefighters Grant Branch, 1–866–274–
0960.
SUPPLEMENTARY INFORMATION: The AFG
Program awards grants directly to fire
departments, nonaffiliated emergency
medical service (EMS) organizations,
and State Fire Training Academies
(SFTA) for the purpose of enhancing the
health and safety of first responders and
improving their abilities to protect the
public from fire and fire-related hazards.
Applications for the FY 2022 AFG
Program are submitted and processed
online through https://go.fema.gov/.
Before the application period started,
the FY 2022 AFG Program Notice of
Funding Opportunity (NOFO) was
published on FEMA’s AFG Program
website at https://www.fema.gov/grants/
preparedness/firefighters/assistancegrants. The AFG Program website
provides additional information and
materials useful for FY 2022 AFG
Program applicants, including
Frequently Asked Questions,
Application Checklist, Narrative Get
Ready Guide, Self-Evaluation Sheets for
Vehicle Acquisition and Operations
Safety, and a Cost-Share Calculator.
Based on past AFG Program application
periods, FEMA anticipates receiving
8,000 to 10,000 applications for the FY
2022 AFG Program and has the ability
to award approximately 2,000 grants.
Pursuant to the Federal Fire
Prevention and Control Act of 1974, as
amended, the Administrator of FEMA is
publishing this notice describing the
fiscal year (FY) 2022 Assistance to
Firefighters Grant (AFG) Program
application process, deadlines, and
award selection criteria. This notice
explains the differences, if any, between
these guidelines and those
recommended by representatives of the
national fire service leadership during
the annual meeting of the Criteria
Development Panel (CDP), which was
held July 12–15, 2022. The application
period for the FY 2022 AFG Program is
January 9–February 10, 2023, and was
announced on the FEMA AFG Program
Congressional Appropriations
For the FY 2022 AFG Program,
Congress appropriated $360 million
through the Department of Homeland
Security Appropriations Act, 2022,
Public Law 117–103. From this amount,
$324 million will be made available for
FY 2022 AFG Program awards. In
addition, section 33 of the Federal Fire
Prevention and Control Act of 1974, as
amended (15 U.S.C. 2229), requires that
a minimum of 10% of available funds be
expended for Fire Prevention and Safety
(FP&S) Program grants. FP&S Program
awards will be made directly to local
fire departments and to local, regional,
state, or national entities recognized for
their expertise in the fields of fire
Dated: January 25, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–01833 Filed 1–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2023–0004]
Assistance to Firefighters Grant
Program
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:30 Jan 27, 2023
Jkt 259001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
prevention and firefighter safety
research and development. The funds
appropriated for FY 2022 are available
for obligation and award until Sept. 30,
2023.
The Federal Fire Prevention and
Control Act of 1974 further directs
FEMA to administer these
appropriations according to the
following requirements:
• Career fire departments: Not less
than 25% of available grant funds.
• Volunteer fire departments: Not less
than 25% of available grant funds.
• Combination fire departments and
departments using paid-on-call
firefighting personnel: Not less than
25% of available grant funds.
• Open competition (career,
volunteer, and/or combination fire
departments and departments using
paid-on-call firefighting personnel): Not
less than 10% of available grant funds
awarded.
• EMS providers including fire
departments and nonaffiliated EMS
organizations: Not less than 3.5% of
available grant funds awarded.
• Nonaffiliated EMS providers: Not
more than 2% of the total available
grant funds.
• SFTAs: Not more than 3% of
available grant funds shall be
collectively awarded to SFTA
applicants, with a maximum of
$500,000 per applicant.
• Vehicles: Not more than 25% of
available grant funds may be used for
the purchase of vehicles; by policy and
based on recommendations, FEMA
intends to dedicate 10% of those vehicle
funds for ambulances.
• Micro grants: This is a voluntary
funding limitation choice made by the
applicant for requests submitted within
the operations and safety activity. It is
not an additional funding opportunity.
Micro grants are awards that have a
Federal participation (share) that does
not exceed $50,000. Applicants that
select micro grants may receive
additional consideration for award. If an
applicant selects micro grants in their
application, they will be limited in the
total amount of funding their
organization can be awarded. If they are
requesting funding in excess of $50,000
federal participation, they should not
select micro grants.
Background of the AFG Program
Since 2001, the AFG Program has
awarded approximately $8.1 billion in
grant funding to help firefighters and
other first responders obtain critically
needed equipment, protective gear,
emergency vehicles, training, and other
resources needed to protect the public
and emergency personnel from fire and
E:\FR\FM\30JAN1.SGM
30JAN1
Agencies
[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Pages 5897-5898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01833]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neuronal Communications Study
Section.
Date: February 23-24, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Prithi Rajan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Prevention Study Section.
Date: February 23-24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD
20852.
Contact Person: Byung Min Chung, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-4056,
[email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Pregnancy and
Neonatology Study Section.
Date: February 23-24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Andrew Maxwell Wolfe, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, (301)
402-3019, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Learning, Memory and Decision
Neuroscience Study Section.
Date: February 23-24, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Roger Janz, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Clinical Data Management and Analysis Study
Section.
Date: February 23-24, 2023.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Shivakumar V. Chittari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 408-9098,
[email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Biomaterials and Biointerfaces Study
Section.
Date: February 23-24, 2023.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shivani Sharma, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 507-7661,
[email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Muscle and Exercise Physiology
Study Section.
Date: February 23-24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, (301) 496-8551, [email protected].
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Drug and Biologic Disposition and Toxicity
Study Section (DBDT).
Date: February 23, 2023.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 5898]]
Contact Person: Stacey Nicole Williams, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Cell Biology Integrated Review Group;
Cellular Mechanisms in Aging and Development Study Section.
Date: February 23-24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel Tapestry Collection by Hilton, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Tami Jo Kingsbury, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 710Q, Bethesda, MD 20892, (410)
274-1352, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 25, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-01833 Filed 1-27-23; 8:45 am]
BILLING CODE 4140-01-P